150 related articles for article (PubMed ID: 21613819)
1. Systemic Par-4 inhibits non-autochthonous tumor growth.
Zhao Y; Burikhanov R; Brandon J; Qiu S; Shelton BJ; Spear B; Bondada S; Bryson S; Rangnekar VM
Cancer Biol Ther; 2011 Jul; 12(2):152-7. PubMed ID: 21613819
[TBL] [Abstract][Full Text] [Related]
2. Cancer-selective apoptotic effects of extracellular and intracellular Par-4.
Shrestha-Bhattarai T; Rangnekar VM
Oncogene; 2010 Jul; 29(27):3873-80. PubMed ID: 20440265
[TBL] [Abstract][Full Text] [Related]
3. Cancer-selective apoptosis by tumor suppressor par-4.
Hebbar N; Shrestha-Bhattarai T; Rangnekar VM
Adv Exp Med Biol; 2014; 818():155-66. PubMed ID: 25001535
[TBL] [Abstract][Full Text] [Related]
4. Cancer resistance in transgenic mice expressing the SAC module of Par-4.
Zhao Y; Burikhanov R; Qiu S; Lele SM; Jennings CD; Bondada S; Spear B; Rangnekar VM
Cancer Res; 2007 Oct; 67(19):9276-85. PubMed ID: 17909035
[TBL] [Abstract][Full Text] [Related]
5. The tumor suppressor Par-4 activates an extrinsic pathway for apoptosis.
Burikhanov R; Zhao Y; Goswami A; Qiu S; Schwarze SR; Rangnekar VM
Cell; 2009 Jul; 138(2):377-88. PubMed ID: 19632185
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of apoptosis by the tumor suppressor Par-4.
Hebbar N; Wang C; Rangnekar VM
J Cell Physiol; 2012 Dec; 227(12):3715-21. PubMed ID: 22552839
[TBL] [Abstract][Full Text] [Related]
7. [Pro-apoptosis and selective anticancer activities of prostate apoptosis response protein 4: research progress and prospects].
Wu Z; Wang G; Zhang K
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jan; 34(1):128-32. PubMed ID: 24463134
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis and tumor resistance conferred by Par-4.
Zhao Y; Rangnekar VM
Cancer Biol Ther; 2008 Dec; 7(12):1867-74. PubMed ID: 18836307
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of Par-4 by protein kinase A is critical for apoptosis.
Gurumurthy S; Goswami A; Vasudevan KM; Rangnekar VM
Mol Cell Biol; 2005 Feb; 25(3):1146-61. PubMed ID: 15657440
[TBL] [Abstract][Full Text] [Related]
10. Caspase-8-mediated PAR-4 cleavage is required for TNFα-induced apoptosis.
Treude F; Kappes F; Fahrenkamp D; Müller-Newen G; Dajas-Bailador F; Krämer OH; Lüscher B; Hartkamp J
Oncotarget; 2014 May; 5(10):2988-98. PubMed ID: 24931006
[TBL] [Abstract][Full Text] [Related]
11. Recombinant Production and Characterization of SAC, the Core Domain of Par-4, by SUMO Fusion System.
Zhang J; Sun A; Dong Y; Wei D
Appl Biochem Biotechnol; 2018 Apr; 184(4):1155-1167. PubMed ID: 28971310
[TBL] [Abstract][Full Text] [Related]
12. The Akt inhibitor ISC-4 activates prostate apoptosis response protein-4 and reduces colon tumor growth in a nude mouse model.
Sharma AK; Kline CL; Berg A; Amin S; Irby RB
Clin Cancer Res; 2011 Jul; 17(13):4474-83. PubMed ID: 21555373
[TBL] [Abstract][Full Text] [Related]
13. Chloroquine-Inducible Par-4 Secretion Is Essential for Tumor Cell Apoptosis and Inhibition of Metastasis.
Burikhanov R; Hebbar N; Noothi SK; Shukla N; Sledziona J; Araujo N; Kudrimoti M; Wang QJ; Watt DS; Welch DR; Maranchie J; Harada A; Rangnekar VM
Cell Rep; 2017 Jan; 18(2):508-519. PubMed ID: 28076793
[TBL] [Abstract][Full Text] [Related]
14. Plant-derived SAC domain of PAR-4 (Prostate Apoptosis Response 4) exhibits growth inhibitory effects in prostate cancer cells.
Sarkar S; Jain S; Rai V; Sahoo DK; Raha S; Suklabaidya S; Senapati S; Rangnekar VM; Maiti IB; Dey N
Front Plant Sci; 2015; 6():822. PubMed ID: 26500666
[TBL] [Abstract][Full Text] [Related]
15. Arylquins target vimentin to trigger Par-4 secretion for tumor cell apoptosis.
Burikhanov R; Sviripa VM; Hebbar N; Zhang W; Layton WJ; Hamza A; Zhan CG; Watt DS; Liu C; Rangnekar VM
Nat Chem Biol; 2014 Nov; 10(11):924-926. PubMed ID: 25218743
[TBL] [Abstract][Full Text] [Related]
16. Caspase-3 mediated release of SAC domain containing fragment from Par-4 is necessary for the sphingosine-induced apoptosis in Jurkat cells.
Thayyullathil F; Pallichankandy S; Rahman A; Kizhakkayil J; Chathoth S; Patel M; Galadari S
J Mol Signal; 2013 Feb; 8(1):2. PubMed ID: 23442976
[TBL] [Abstract][Full Text] [Related]
17. The Ras effector RASSF2 controls the PAR-4 tumor suppressor.
Donninger H; Hesson L; Vos M; Beebe K; Gordon L; Sidransky D; Liu JW; Schlegel T; Payne S; Hartmann A; Latif F; Clark GJ
Mol Cell Biol; 2010 Jun; 30(11):2608-20. PubMed ID: 20368356
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of Par-4 combined with cisplatin on human Wilms' tumor cells.
Wang J; Li Y; Ma F; Zhou H; Ding R; Lu B; Zou L; Li J; Lu R
Tumour Biol; 2017 Jul; 39(7):1010428317716689. PubMed ID: 28720068
[TBL] [Abstract][Full Text] [Related]
19. The Par-4-GRP78 TRAIL, more twists and turns.
Lee AS
Cancer Biol Ther; 2009 Nov; 8(22):2103-5. PubMed ID: 19823030
[TBL] [Abstract][Full Text] [Related]
20. Secretory expression of Par-4 SAC-HA2TAT following adeno-associated virus-mediated gene transfer induces apoptosis in HepG2 cells.
Qin TJ; Ma W; Liu SX; Yang GX; Wang QY; Zhao XH
Mol Med Rep; 2010; 3(5):749-57. PubMed ID: 21472309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
